Skip to content

Clinical trials

Leiomyosarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyosarcoma Country / region: United States Clear all

95 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20033
20043
20052
20067
20073
20083
20094
20102
20113
20124
20131
20141
20154
20162
20174
20181
20197
20205
20216
20225
20234
20246
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Recruiting19
Terminated15
Active, not recruiting8
Unknown status4
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)12
Memorial Sloan Kettering Cancer Center10
M.D. Anderson Cancer Center5
Dana-Farber Cancer Institute3
Eli Lilly and Company3
European Organisation for Research and Treatment of Cancer - EORTC3
Baylor College of Medicine2
Brown University2
City of Hope Medical Center2
Fred Hutchinson Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyosarcoma95
Sarcoma58
Liposarcoma44
Histiocytoma, Malignant Fibrous36
Sarcoma, Synovial32
Fibrosarcoma22
Hemangiosarcoma22
Neurofibrosarcoma21
Dermatofibrosarcoma17
Osteosarcoma13

Trials

Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.